268 related articles for article (PubMed ID: 26683987)
1. A highly sensitive and selective LC-MS/MS method to quantify asunaprevir, an HCV NS3 protease inhibitor, in human plasma in support of pharmacokinetic studies.
Kandoussi H; Jiang H; Zeng J; Zheng N; Kadiyala P; Eley T; He B; Garimella T; Demers R; Cojocaru L; Aubry AF; Arnold ME
J Pharm Biomed Anal; 2016 Feb; 119():145-51. PubMed ID: 26683987
[TBL] [Abstract][Full Text] [Related]
2. A rugged and accurate liquid chromatography-tandem mass spectrometry method for the determination of asunaprevir, an NS3 protease inhibitor, in plasma.
Yuan L; Jiang H; Ouyang Z; Xia YQ; Zeng J; Peng Q; Lange RW; Deng Y; Arnold ME; Aubry AF
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():81-6. PubMed ID: 23435345
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma.
Jiang H; Kandoussi H; Zeng J; Wang J; Demers R; Eley T; He B; Burrell R; Easter J; Kadiyala P; Pursley J; Cojocaru L; Baker C; Ryan J; Aubry AF; Arnold ME
J Pharm Biomed Anal; 2015 Mar; 107():409-18. PubMed ID: 25676854
[TBL] [Abstract][Full Text] [Related]
4. Development of simple and rapid LC-MS/MS method for determination of celecoxib in human plasma and its application to bioequivalence study.
Park MS; Shim WS; Yim SV; Lee KT
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():137-41. PubMed ID: 22771234
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of glimepiride and pioglitazone in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study.
Ni XJ; Wang ZZ; Shang DW; Zhang M; Hu JQ; Qiu C; Wen YG
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():247-52. PubMed ID: 24835512
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor.
Mosure KW; Knipe JO; Browning M; Arora V; Shu YZ; Phillip T; Mcphee F; Scola P; Balakrishnan A; Soars MG; Santone K; Sinz M
J Pharm Sci; 2015 Sep; 104(9):2813-23. PubMed ID: 25631585
[TBL] [Abstract][Full Text] [Related]
8. A rapid, accurate and robust UHPLC-MS/MS method for quantitative determination of BMS-927711, a CGRP receptor antagonist, in plasma in support of non-clinical toxicokinetic studies.
Zheng N; Zeng J; Akinsanya B; Buzescu A; Xia YQ; Ly V; Trouba K; Peng Q; Aubry AF; Arnold ME
J Pharm Biomed Anal; 2013 Sep; 83():237-48. PubMed ID: 23770636
[TBL] [Abstract][Full Text] [Related]
9. Validation of an electrospray ionisation LC-MS/MS method for quantitative analysis of telaprevir and its R-diastereomer.
Penchala SD; Tjia J; El Sherif O; Back DJ; Khoo SH; Else LJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():100-10. PubMed ID: 23831525
[TBL] [Abstract][Full Text] [Related]
10. An LC/MS quantitative and microdialysis method for cyclovirobuxine D pharmacokinetics in rat plasma and brain: The pharmacokinetic comparison of three different drug delivery routes.
Wei JB; Lai Q; Shumyak SP; Xu LF; Zhang CX; Ling JJ; Yu Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():185-93. PubMed ID: 26342162
[TBL] [Abstract][Full Text] [Related]
11. Rapid and sensitive determination of vinorelbine in human plasma by liquid chromatography-tandem mass spectrometry and its pharmacokinetic application.
Qian J; Wang Y; Chang J; Zhang J; Wang J; Hu X
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(9-10):662-8. PubMed ID: 21342795
[TBL] [Abstract][Full Text] [Related]
12. Asunaprevir: An HCV Protease Inhibitor With Preferential Liver Distribution.
Eley T; Garimella T; Li W; Bertz RJ
Clin Pharmacol Drug Dev; 2017 Mar; 6(2):195-200. PubMed ID: 28263460
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of bentysrepinine (Y101) and its metabolites M8 and M9 in human plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Liu X; Huang C; Xue L; Xu Q; Xia W; Li X; Miao L
J Pharm Biomed Anal; 2018 Feb; 150():287-293. PubMed ID: 29258048
[TBL] [Abstract][Full Text] [Related]
14. The effect of hepatic impairment on the pharmacokinetics of asunaprevir, an HCV NS3 protease inhibitor.
Eley T; He B; Chang I; Colston E; Child M; Bedford W; Kandoussi H; Pasquinelli C; Marbury TC; Bertz RJ
Antivir Ther; 2015; 20(1):29-37. PubMed ID: 24704773
[TBL] [Abstract][Full Text] [Related]
15. Determination of palonosetron in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.
Yang S; Qin F; Wang D; Li N; Li F; Xiong Z
J Pharm Biomed Anal; 2012 Jan; 57():13-8. PubMed ID: 21937184
[TBL] [Abstract][Full Text] [Related]
16. A highly sensitive method for the quantification of fludrocortisone in human plasma using ultra-high-performance liquid chromatography tandem mass spectrometry and its pharmacokinetic application.
Banda J; Lakshmanan R; Vvs SP; Gudla SP; Prudhivi R
Biomed Chromatogr; 2015 Aug; 29(8):1213-9. PubMed ID: 25611194
[TBL] [Abstract][Full Text] [Related]
17. Rapid and sensitive LC-MS/MS method for determination of megestrol acetate in human plasma: application to a human pharmacokinetic study.
Seo JH; Park JS; Jo MH; Park MS; Ryu JH; Cho YW; Shim WS; Noh GJ; Lee KT
Biomed Chromatogr; 2013 Apr; 27(4):409-15. PubMed ID: 22961730
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of UFLC-MS/MS method for determination of bosentan in rat plasma.
Atila A; Ozturk M; Kadioglu Y; Halici Z; Turkan D; Yayla M; Un H
J Pharm Biomed Anal; 2014 Aug; 97():33-8. PubMed ID: 24803031
[TBL] [Abstract][Full Text] [Related]
19. Effect of disease state on ionization during bioanalysis of MK-7009, a selective HCV NS3/NS4 protease inhibitor, in human plasma and human Tween-treated urine by high-performance liquid chromatography with tandem mass spectrometric detection.
Anderson MD; Breidinger SA; Woolf EJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1047-56. PubMed ID: 19328051
[TBL] [Abstract][Full Text] [Related]
20. A novel UPLC-MS/MS method for sensitive quantitation of boldine in plasma, a potential anti-inflammatory agent: application to a pharmacokinetic study in rats.
Zeng RJ; Li Y; Chen JZ; Chou GX; Gao Y; Shao JW; Jia L; Wu SD; Wu SS
Biomed Chromatogr; 2015 Mar; 29(3):459-64. PubMed ID: 25065486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]